SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-024891
Filing Date
2023-08-30
Accepted
2023-08-30 17:16:08
Documents
13
Period of Report
2023-08-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20230828_8k.htm   iXBRL 8-K 26871
  Complete submission text file 0001437749-23-024891.txt   166225

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20230828.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20230828_def.xml EX-101.DEF 12187
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20230828_lab.xml EX-101.LAB 16396
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20230828_pre.xml EX-101.PRE 12457
7 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20230828_8k_htm.xml XML 2757
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 231226110
SIC: 2834 Pharmaceutical Preparations